Zimmer Biomet Holdings (ZBH) Other financing activities (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Other financing activities came in at $12.3 million in Q1 2026, up 180.92% year-on-year from $4.4 million in Q1 2025, and up 122.08% quarter-over-quarter from -$55.7 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other financing activities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other financing activities history runs 18 years deep, the most recent figure standing at $12.3 million for Q1 2026.
- On a quarterly basis, Other financing activities rose 180.92% year-over-year to $12.3 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 110.43% increase from a year earlier, with the FY2025 full-year figure at -$17.7 million, up 20.98% from the prior year.
- Other financing activities rose to $12.3 million in Q1 2026 per ZBH's latest filing, from -$55.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $107.9 million in Q4 2023 and bottomed at -$76.7 million in Q2 2024.
- The 5-year median for Other financing activities is $4.3 million (2022), against an average of $325000.0.
- Across the five-year window, Other financing activities jumped 12650.0% in 2023 and sank 411.01% in 2025, its largest moves.
- Year by year, Other financing activities stood at -$64.6 million in 2022, then surged by 267.03% to $107.9 million in 2023, then sank by 110.1% to -$10.9 million in 2024, then sank by 411.01% to -$55.7 million in 2025, then soared by 122.08% to $12.3 million in 2026.
- Per Business Quant, the three latest ZBH Other financing activities figures stand at $12.3 million (Q1 2026), -$55.7 million (Q4 2025), and $20.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.30 Mn |
| Mar 31, 2026 | 12.30 Mn |
| Dec 31, 2025 | -55.70 Mn |
| Dec 31, 2025 | -55.70 Mn |
| Sep 30, 2025 | 20.90 Mn |
| Sep 30, 2025 | 20.90 Mn |
| Jun 30, 2025 | 32.30 Mn |
| Jun 30, 2025 | 32.30 Mn |
| Mar 31, 2025 | -15.20 Mn |
| Mar 31, 2025 | -15.20 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Dec 31, 2024 | -10.90 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Jun 30, 2024 | -76.70 Mn |
| Jun 30, 2024 | -76.70 Mn |
| Mar 31, 2024 | 56.40 Mn |
| Mar 31, 2024 | 56.40 Mn |
| Dec 31, 2023 | 107.90 Mn |
| Dec 31, 2023 | 107.90 Mn |